SDA Bocconi’s skills and competencies make it the best fit to become the first “non technological” School to address coherently and rigorously convergence between digital Technologies and Life Sciences, and its business impact across industries.
The need for a better understanding of the innovation driven by biotech and convergence between digital and life sciences is clearer than ever. Big Tech investments in life sciences and health have consistently grown since 2012 signaling cross-fertilization between sectors. A growing aging population demands new products, services and solutions that venture capitalists are looking forward to funding.
The most recent pandemic has opened up a more vibrant debate around how innovate traditional clinical trial models and new drug discovery processes. A great deal of new “cool technologies” will take over the glossy cover pages of magazines this decade. This is going to be the Life Science decade as last decade has been the A.I. decade. Which one of these new technologies is proficient? Which one is ready to scale to consumers? Which one is ready to scale to consumers?Which regulatory implications will this new technology bring in? Is this new technology ready for my organization? Is my organization ready for this new technology?
The importance of assessing technologies’ readiness for scaling and adoption is paramount to guide not only investments, but also organizational change and regulations.
On top of a multidisciplinary faculty covering business from all perspectives, the LIFT Lab can rely on the cooperation with two, well established SDA Bocconi competence centers (CERGAS, Center for Research on Health and Social Care Management and DEVO Lab) and a partnership with the Massachusetts Institute of Technology - M.I.T, one of the top research centers in the field of technologies for life sciences.